Ovid Therapeutics Inc. Common Stock (NASDAQ: OVID) last traded at $2.80, up 2.19% on the session. The quote above updates while this page is open; the figures below are drawn from Ovid Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Ovid Therapeutics Inc. Common Stock trades on NASDAQ under the ticker OVID. Its market capitalisation is $546.83 million.
Valuation measures for Ovid Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $546.83M |
|---|---|
| Enterprise value | $557.59M |
| Price / sales | 345.44 |
| Price / book | 2.61 |
| Beta | 1.23 |
Trailing-twelve-month figures tagged in Ovid Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.58M |
|---|---|
| Net income (TTM) | -$34.49M |
| Operating margin | -3686.67% |
| Return on equity | -16.43% |
| Cash | $11.33M |
Range and volume for OVID over the past 52 weeks.
| 52-week high | $3.11 |
|---|---|
| 52-week low | $1.05 |
| Volume | 1.33M |
| Average volume | 2.30M |
| Previous close | $2.74 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.